1 / 23

Stress, Anxiety & Depression: So What Do I Take?

Stress, Anxiety & Depression: So What Do I Take?. Gary E. Foresman, MD July 2013. References. Depression and Risk of Stroke Morbidity and Mortality. An Pan PhD, et al. JAMA. Sept 21, 2011; 306(11): 1241-1249.

sakina
Download Presentation

Stress, Anxiety & Depression: So What Do I Take?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Stress, Anxiety & Depression:So What Do I Take? Gary E. Foresman, MD July 2013

  2. References • Depression and Risk of Stroke Morbidity and Mortality. An Pan PhD, et al. JAMA. Sept 21, 2011; 306(11): 1241-1249. • Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy. Erick H Turner MD, et al. NEJM. Jan 17, 2008;358: 252-60. • Effectiveness of Antidepressants: An Evidence Myth Constructed From a Thousand Clinical Trials? John P Ioannidis. Philosophy, Ethics, and Humanities in Medicine. May 27, 2008; 3:14. • Complementary and Alternative Medicine For the Treatment of Major Depressive Disorder. Richard Nahas MD, et al. Canadian Fam Phys. June 2011; 57: 659-63. • St. John’s Wort and SAMe as Natural Alternatives to Conventional Antidepressants… David J Carpenter, PharmD. Alt Med Rev. 2011;16(1): 17-39.

  3. References • Nutritional and Herbal Supplements for Anxiety and Anxiety-Related Disorders: Systematic Review. Lakhan, Shaheen and Vieira, Karen, Nutrition Journal 2010, 9:42 p1-14. • Kava in the Treatment of Generalized Anxiety Disorder: A DBPCRCT. Sarris, J etal. J ClinPsychopharmacol Apr 2013. • The Acute Effects of Kava and Oxazepam on Anxiety, Mood, Neurocognition: A DBPCRCT. Sarris, J etal. Hum Psychopharmacology May 2012: 27(3): 262-9. • An Orally Administered Lavandula Oil Preparation for Anxiety and Related Conditions: an Evidence Based Review. Kasper s. In J Psychiatry ClinPract Jun 2013.

  4. Depression: An Introduction • Depression affects between 16-20% of the population during their lifetime. Anxiety affects almost exactly the same number of people. • Depression is associated with sedentary lifestyle, poor diet, smoking, obesity, and an increased risk of Diabetes Mellitus, Hypertension, and Coronary Artery Disease. • Depression has neuroendocrine dysfunction, specifically sympathetic nervous system activation, hypothalamic–pituitary-adrenal dysregulation and increased platelet aggregation.

  5. Depression: An Introduction • Depression is an inflammatory disorder associated with disruption of bowel flora and increased inflammatory mediators such as CRP, IL-1 and IL-6. • Depression increases stroke risk by 45%, and fatal stroke by 55%. • Antidepressant medicines are strongly associated with stroke risk (as well as osteoporosis). • Antidepressant medicines, NOT depression itself, have been strongly correlated with brain atrophy, specifically in the hippocampus. (J of Alzheimer’s Disease. Feb 2012)

  6. Mark Twain’s Three Cents: “If you don't read the newspaper, you're uninformed. If you read the newspaper, you're mis-informed.” “The easy confidence with which I know another man's religion is folly teaches me to suspect that my own is also.” “Be careful about reading health books. You may die of a misprint.”

  7. Publication Bias • An analysis of 74 FDA-registered studies between 1987-2004 used for the approval of 12 antidepressant agents were reviewed. • Of the 38 trials favoring the medicine over placebo, 37 were published. • Of the 36 trials favoring placebo (or showing no difference) only 3 were published as showing “not positive” results

  8. Publication Bias • Of the 36 trials showing unfavorable results an additional 11 publications went to press showing “favorable” results in direct conflict with the FDA’s conclusions. • When all studies are combined a very slight statistical advantage for the medicines persist, at a level that does not reach the standard for “clinical significance”.

  9. Pharmaceutical Influence • Nearly 30% of the $80 billion spent on depression in the USA is spent on drug expenses. • A review of drug efficacy notes that as depression becomes more severe, the clinical trials do not show that the medicines are more effective, only that placebos become more ineffective, giving the illusion of improved drug efficacy. • Most antidepressant trials rarely last more than 8 weeks, long term efficacy and safety have never been established.

  10. Pharmaceutical Influence • Direct to Consumer advertising builds up a “scientific” mythology that negates the actual neuro-biological complexity that is depression; nearly 94% of antidepressant use generated by these ads are by non-depressed individuals. • Fluoxetine (Prozac) received FDA approval after 5 trials that involved 817 depressed patients. Today over 50,000 people have received prescriptions for this medicine. • Is it ethical to prescribe these meds? To not prescribe?

  11. The Dangers of Inaction • In 2004, changed warning labels indicating an increased risk of suicide for teens taking SSRIs lead to a decrease in diagnosis and treatment of depression, which led to: • A reversal of a decades long trend in a decreasing rate of teen suicide. • The answer has never been to do nothing.

  12. Diagnosing People, Not Diseases • Melancholia (black bile): the only diseases felt to be caused by an excess of “black bile” are depression and cancer. • Diagnosing the person with depression, not identifying symptom patterns and looking for magic bullets. • Symptoms drive the need for behavior change, integrative medicine is not about substituting supplements for medicines, it is about treating both the etiology and the symptoms, where as medicines serve as a necessary “safety net”.

  13. Beginning to Treat Depression • The Foundations of Health (the role of nutrition/exercise/ stress management) • “All Senses for Healing” • History/Physical/Extensive Lab Assessment • Basic Nutritional Protocol (the role of multi-vitamins, fish oils, D3, and probiotics) • Supportive Supplementation • Detoxification and Sleep Support • Sexual Health • www.middlepathmedicine.com

  14. General Treatment Principals • All Senses For Healing As your patient and their family is in so much of a fear-based state, never has there been a more important time for wholism and ‘center-stage’ principals. • Visual: discuss all videos/TV/news programs that they watch. Focus on time in nature, home beauty, FengShui • Auditory: music as medicine, singing bowls, the non-local effects of harmony

  15. General Treatment Principals • Laughter: the audio-visual continuum • Smell: Essential Oils/aromatherapy, the power of personal experience • Taste: the conscious use of spices; healthy shopping and cooking • Touch: how touch deficiency exists whereas chemotherapy deficiency does not. All organic skin care and home care products. The life–transforming power of cancer (depression) to heal.

  16. St. John’s Wort • St. John’s Wort (SJW) is a flowering plant used medicinally for centuries and regulated as an antidepressant in Germany • Inhibits reuptake of at least 5 neurotransmitters, exact mechanism of action and key components yet to be elucidated • Standard dosage is 900mg daily standardized to 0.3% hypericin and/or 3-5% hyperforin • Of 15 evaluable trials in mild to moderate depression, 10 show positive results, and a treatment effect larger than those seen with medicines. • No good long-term trials, many potential drug interactions and a lack of proven efficacy in severe depression limit its utility. • No reported suicidal ideation and an absolute lack of significant side-effects are strong positives and SJW should be considered first line therapy in mild-mod depression.

  17. SAMe • SAMe – S-Adenosyl Methionine • A naturally occurring combination of ATP with the amino acid methionine • Low SAMe has been found in the CSF of depressed patients and improvements in SAMe correlate with clinical improvements. • Functions as a methyl donor, leads to increased cerebral serotonin, dopamine and norepinephrine • Also useful for joints and liver function • Positive results in 5/9 studies in mild-mod depression and 4/5 trials in mod-severe depression • My experience shows SAMe to be by far the most useful and safest of all natural or drug antidepressants. Clinical trials confirm that it can be a powerful adjunctive treatment when added to drug antidepressants.

  18. Other Considerations • 5HTP, L-tyrosine, DLPA and other amino acids • Lithium orotate, Deproloft-HF by Thorne • Anti-anxiety supplements: kava, holy basil, theanine, Rescue Remedy, and more • Theanine Serene with Relorafrom Source Naturals, and Stress-Defy by Irwin Naturals • Ultra-Mag and Magnesium Serene • The role for energy medicine, essential oils: Lavela (Integrative Therapuetics) specifically, and light therapy • New Medicines: intravenous nutritionals

More Related